Airbus - Financial Statements 2022

4. Notes to the IFRS Company Financial Statements Capital Structure and Financial Instruments

Authorisations Granted by the Annual’ General Meeting of Airbus SE Held on 12 April 2022

On 12 April 2022, the AGM of the Company authorised the Board of Directors, for a period expiring at the AGM to be held in 2023, to issue shares and to grant rights to subscribe for shares in the Company’s share capital for the purpose of: ESOPs and share ‑ related LTIPs, provided that such powers shall be limited to an aggregate of 0.14% of the Company’s authorised share capital (see “– Note 33: Share ‑ Based Payment” of the Consolidated Financial Statements); – funding the Company and its subsidiaries, provided that such powers shall be limited to an aggregate of 0.3% of the Company’s authorised share capital (see “– Note 37.3: Financing Liabilities” of the Consolidated Financial Statements). –

For each operation, such powers shall not extend to issuing shares or granting rights to subscribe for shares if there is no preferential subscription right and for an aggregate issue price in excess of €500 million per share issuance. Also on 12 April 2022, the AGM authorised the Board of Directors for an 18 months period to repurchase up to 10% of the Company’s issued share capital at a price per share not less than the nominal value and not more than the higher of the price of the last independent trade and the highest current independent bid on the trading venues of the regulated market of the country in which the purchase is carried out. Furthermore, the AGM authorised the Board of Directors to determine on a case by case basis the share repurchase programme to be implemented by the Company, if any.

Reconciliation Consolidated to Company Equity and Net Income

The difference between the total shareholders’ equity according to the Consolidated Financial Statements and Company’s Financial Statements as at 31 December 2022 and 2021 is as follows:

2022

2021

(In € million)

Consolidated equity

12,950

9,466

OCI - Restatement of investments from Consolidated to Company Financial Statements Retained Earnings - Restatement of investments from Consolidated to Company Financial Statements

4,382

1,864

(9,819)

(2,610)

Retained Earnings - Valuation investments at historical cost

1,487

1,487

Retained Earnings - Impairment of financial assets

(1,025)

(1,029)

Company’s equity

7,975

9,178

The difference between the net income according to the Consolidated Financial Statements and Company’s Financial Statements for the year ended 31 December 2022 and 2021 is as follows:

2022

2021

(In € million)

Consolidated net income

4,247

4,213

Income from investments according to Consolidated Financial Statements

(4,012)

(4,571)

Income from investments according to Company Financial Statements

200

17

Loss on / Impairment of financial assets

0

244

Other valuation differences

0

(17)

Company’s net income (Profit or loss for the period)

435

(114)

113